{"name":"Evofem Inc.","slug":"evofem-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2017-01-01","label":"Solosec first approved","drug":"Solosec","drugSlug":"secnidazole","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Amphora","genericName":"Amphora","slug":"amphora","indication":"Other","status":"marketed"},{"name":"Conceptrol","genericName":"Conceptrol","slug":"conceptrol","indication":"Other","status":"marketed"},{"name":"EVO100","genericName":"EVO100","slug":"evo100","indication":"Contraception in women of reproductive age","status":"phase_3"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Solosec","genericName":"SECNIDAZOLE","slug":"secnidazole","indication":"Bacterial vaginosis","status":"marketed"}]}],"pipeline":[{"name":"Amphora","genericName":"Amphora","slug":"amphora","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Conceptrol","genericName":"Conceptrol","slug":"conceptrol","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"EVO100","genericName":"EVO100","slug":"evo100","phase":"phase_3","mechanism":"EVO100 is a vaginal contraceptive film that provides non-hormonal contraception through a spermicidal mechanism.","indications":["Contraception in women of reproductive age"],"catalyst":""},{"name":"Solosec","genericName":"SECNIDAZOLE","slug":"secnidazole","phase":"marketed","mechanism":"Solosec works by entering susceptible microorganisms and disrupting their DNA, ultimately leading to cell death.","indications":["Bacterial vaginosis","Giardiasis","Infection by Trichomonas"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimgJBVV95cUxQdUJGZS0tU1dDaGJILTZiWFVsYTBxNnFacnFzLUNpNWYtb09najdXcWVGdGtwdHZwandIRnZCYVhDcHhvb0ZIRWFXdXlXcGpCOElSb29EMzUyY3pPdVFfaWQ1ckJCSDZQV3lfNlNOSUJwNU1ZbEtBT2hBZXlDRHdGWFgweGN4aGxXTEFrVjVIWmJWVElyOGpjcDhUVWJzMFVveVc4U3g2UGI0b2NDTFh5aWJpd2diajNCRmx0V2t4a2hwcHloUWtGZE1xelBzR29waXRGd2NUell2QjN3VXhkUVdtbXpva19ocHVJSE03OEVXaFlYVFRwZVlycktTSmpPTVhUc0FUcHhNWTNPMEYtUkY1ei1lMUl2UFE?oc=5","date":"2025-11-21","type":"pipeline","source":"PR Newswire","summary":"Favorable Pricing Certificates Issued for Evofem's PHEXX by Emirates Drug Establishment are Launching Step for Commercialization in UAE - PR Newswire","headline":"Favorable Pricing Certificates Issued for Evofem's PHEXX by Emirates Drug Establishment are Launching Step for Commercia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxNQktkQ055TVVaUTB2Sy1vRHFaWDZfUFFWbEs5QzFIa2NqanZ4MWdDdDNCTVJEeVRPSXpCNnEtcm1kY1ZEd0NINFhZMjJidWhialEzc1gwd3Y4UXhqSm10X080MXN2NTd6RlVTa1M0c21TT010ME5ndDRZZjlMVDIwMlFqM19oWlRuM1BSQ0FfN0dmeWRpd0Z5eDcwd0pfbmhuTGtyQ3c5ZFpZSnFJeFUyQldDX1BYS196STBkMlhfZVFrMV9ldmdZ?oc=5","date":"2025-10-01","type":"regulatory","source":"PR Newswire","summary":"Evofem's SOLOSEC Submitted for Marketing Approval in United Arab Emirates - PR Newswire","headline":"Evofem's SOLOSEC Submitted for Marketing Approval in United Arab Emirates","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxOT0s5eW1wMUpVeE1RUW5TWVpBNENYUU9zMlc4dmhmeFMyUnRUcTVRY05RdllRN29uWnhKNlUzUVFLdTBTSGJzRndjeWlVejZtek9rTDdjVW5RNXpxaHZuZUhfVFpUd2ZJNXNYWmFNZTI4akRZY0RuTV9UTmN3SDZTQWRILWxiNXN2bUNUeg?oc=5","date":"2025-07-09","type":"pipeline","source":"San Diego Business Journal","summary":"Evofem Eying Middle East Markets - San Diego Business Journal","headline":"Evofem Eying Middle East Markets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxOQXZWMkV0bXJkWWpLbVFrV2tFTzN1Y1lsd3FQYzVkcWlzbWlING1rRmxBOUVJOHBrR21EYTBkajNGbG9mNnJ3TDh1VGl3ZlpkZ0V5RExUNWZ3RUtkOVExQ1dPeXFjWmZzSWhCTHY5TG5kNkdranVqb3VmN2dCN05XMy1pU1hVRmlONDAtdC1XTkw2SFJtYktEQWdzd3ZDS3BubWg2NjBNcTZjUTVrNXVxUTM5N2l1akpuMDlqT0k1akhSRmxqbzJxdE1VQlF3MlJuRFhNTzQ4SEJwZ19oOFdrN3dXSUk?oc=5","date":"2025-06-23","type":"regulatory","source":"PR Newswire","summary":"Evofem's PHEXXI Submitted for Marketing Approval in United Arab Emirates by Pharma 1 Drug Store - PR Newswire","headline":"Evofem's PHEXXI Submitted for Marketing Approval in United Arab Emirates by Pharma 1 Drug Store","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE50bi1qSFlTak1sdXB1eDMyd1l3NEFrX3NnaGtxWWEzQWpKS0VKakp5SjhENGZGaHpSTUt0V0x3THBfQmhmTExCNTFEUmN4M1dDWkZEZDA1V3hYX0E1c1FBOGpkN3dfd2JXZ3ZrQkxiSG1kendl?oc=5","date":"2024-07-24","type":"regulatory","source":"Procopio","summary":"Women’s Health Innovator Secures New FDA-Approved Drug While Inking Middle East Licensing Deal - Procopio","headline":"Women’s Health Innovator Secures New FDA-Approved Drug While Inking Middle East Licensing Deal","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQcWZRQXF2NmJncmR3U1VueGw5UUQ3RFhSbzlyQVNTVDFYRjhmS0NURUJ2NDR3Q0tKNEpLend6Uy1lVnBvRkg0RE9HNXFBVGViOGhGdTVhbDZkU0xwRkh1M1FfYW1jV2tucU1sSGNKaUYtVHFFUUxpVHhkdEJ2blhYX0NLRTZZQkZtMTBDQ05yNlFlZEw0a1h3QkNhR1Bzc3JwclNpRVRuZHZpV0RKNTFhcFZCMHoyeXNOX0Z3R2s4eTk?oc=5","date":"2024-07-23","type":"deal","source":"PR Newswire","summary":"Evofem Signs Phexxi® License Agreement for Middle East with Pharma 1 - PR Newswire","headline":"Evofem Signs Phexxi® License Agreement for Middle East with Pharma 1","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOUVhSMkYtZnNqSlpRVERQRmh5TVlIWjV6MEp6ek5TVHZLNTg4ZTNsV1NXdGRzTjdRakhhVFBjVUliVDlCbDhjYkZUcDhnamxqbjZkLXBmU3htRnB1LVNRX1hBanFmdGpaMVdtek11Ty1uYjc2czd6NDJuTGx2SjQ4ZkF0Nm5IZzc4LVJ6eDdVSFNqLVo5WHVTUlhOdGRoaFZMQmxxMi1TSEFUYVlLSExz?oc=5","date":"2023-12-13","type":"deal","source":"Pharmaceutical Technology","summary":"Aditxt acquires Phexxi contraceptive gel-maker Evofem for $100m - Pharmaceutical Technology","headline":"Aditxt acquires Phexxi contraceptive gel-maker Evofem for $100m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNMGd6N3NBc1F1amZXMS1BSWRJVDQ3TFh1ZVUtV0wzZWkzdzQzc1BpTEtkczdzc3E2aXZ4eGRhMnZEeTFVekt3Skt6V1VNNWNXX2dwRWtDOU5HMWpOYnVyZXBlVURLYmVualpKbzJLcEczMDZJd05qOUJCS0dueXRfalVEdmdSQVRCT3N1OTBxbjNPbE5JU1VuQzEtcWJzNWgtaWdJZ2ExR1pabi1XUkRPaTRhTmtPUQ?oc=5","date":"2023-12-12","type":"deal","source":"Fierce Pharma","summary":"Troubled Evofem, marketer of contraceptive gel Phexxi, sells itself to Aditxt in $100M deal - Fierce Pharma","headline":"Troubled Evofem, marketer of contraceptive gel Phexxi, sells itself to Aditxt in $100M deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE9YYVJJUlFud3lfVHVVRjFJRDdQZ04xbDE1QzlwTkhXMEM5Sk1IYUQtNkpfcmlBM3Y1dDRKczY5WnVkSDlXR29GSzNsRjg2ZF94czFhTmRWdkVMMjVUVklLSnp3cmlzX3ZUR19wQjd6Uzh3SW5sNUE?oc=5","date":"2023-04-11","type":"pipeline","source":"fortune.com","summary":"She spent a decade trying to build better women's health care—now her startup is on the brink of failure - fortune.com","headline":"She spent a decade trying to build better women's health care—now her startup is on the brink of failure","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE10T2hDMkZOMHQ3cHZQUEJBMFlvUE42VW5ITDhTNWhGQjBoLWg0akNkcXRraGhsanJhUi1WOVNndTJwWUU1RmlxbDFhQ1hQbF9Ga0JFUWYwS2VCWmN3cFF1WWZ2VGdTQUNiQW5kWGhrZFdkZnpRN2ln?oc=5","date":"2023-04-10","type":"pipeline","source":"fortune.com","summary":"‘Anything to survive’: How one leader is pushing ahead - fortune.com","headline":"‘Anything to survive’: How one leader is pushing ahead","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPN2k2bmQ0aHF3MVFxY2l1bHJFaEJjUWMyd0NMNXMyX091Q25kYl9rTU9OSzBGQVBodUJmdC1md2cwRHB0NklaM1VpOVF5TXl0NG5SRzVRcF82QlBfY2VXUWp5NHdQUVJkTGVhYndEMFBXVlV3NEdjMDM5eGJKTVZyeFBDXy1DOGtCSERpS1k0cEdDNnM?oc=5","date":"2022-10-11","type":"pipeline","source":"PharmaLive","summary":"OCI 2022: Evofem Biosciences – Phexxi: Where women call the shots - PharmaLive","headline":"OCI 2022: Evofem Biosciences – Phexxi: Where women call the shots","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOTC1CTndaNHQ5UkxBVWQtdGROTW5NbF9rZ2ZSRnMyVFBNMlhnTm5fOFBraFk5ZHRVT0xjZk5GQ2poWUdHRUtOZHhLT0NkMXFRNEZ3N3ptb3BheG42WVgxYkZxWXNDdXV1dUZPTjI4Rm1KOURBcmxySmNvbEdxYjZsdzlTeGFQYTY0dXU1WDBHVzJXdUUtM0Z3QXBVRUVxRHlGOFBzUDg0WXV1RHhKakdj?oc=5","date":"2019-08-08","type":"pipeline","source":"Bloomberg.com","summary":"Better Birth Control Could Exist, But It Wouldn’t Pay for Big Pharma - Bloomberg.com","headline":"Better Birth Control Could Exist, But It Wouldn’t Pay for Big Pharma","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"marketed":3,"phase_3":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}